VICE: Impact of Self-visualization of Epileptic Seizures on Patients' Perception of the Disease and Risk Behavior

Sponsor
Parc de Salut Mar (Other)
Overall Status
Completed
CT.gov ID
NCT04311151
Collaborator
Germans Trias i Pujol Hospital (Other)
200
2
36.6

Study Details

Study Description

Brief Summary

In Spain, an estimated 690,000 persons have epilepsy, of whom 270,000 have active epilepsy (defined as those who have had a seizure in the last 5 years). It is estimated that 30% of patients diagnosed with epilepsy are drug-resistant. Patients with loss of consciousness or impaired awareness during seizures are at higher risk of injury due to accidents. To prevent such injuries, it is important that patients are sufficiently knowledgeable about their disease to allow them to avoid risk behavior.

In this project, we want to know if visualization of self seizures has an impact on the perception of the severity of the disease, as well as on the risky behavior habits.

Condition or Disease Intervention/Treatment Phase
  • Procedure: own seizures visualization
N/A

Detailed Description

Design: Quasi-experimental study with a control group. Intervention group: standard of care and self-visualization of epileptic seizures. Control group: standard of care.

Main aims:

To determine whether self-visualization of seizures in patients with epilepsy modifies risk perception compared with patients not viewing their own seizures.

To determine whether viewing their seizures leads patients with epilepsy to plan changes in their risk behavior compared with patients not viewing their own seizures.

Design: Quasi-experimental study with a control group. Intervention group: standard of care and self-visualization of epileptic seizures. Control group: standard of care.

Sample size: Accepting an alpha risk of 0.05 and a beta risk lower than 0.2 on bilateral comparison, 50 participants will be needed in the intervention group and 25 in the control group to detect statistically significant differences between the proportion of patients showing behavioral change. It is expected that behavioral change will occur in 40% of the intervention group and 10% of the control group and that losses to follow-up will be 10%.

Variables: Sociodemographic, risk perception, intention to change behavior, perception of disease severity, quality of life, mood/depression, personality traits, anxiety.

Data collection: pre and post visualization of self seizures, and three months after discharge.

A descriptive analysis will be performed, with percentages and frequencies for qualitative variables and mean ± standard deviation (or median [range] depending on the normality of the distribution) for quantitative variables. Inferential analysis will be conducted with the chi-square test or nonparametric tests depending on the behavior of the variables obtained.

This project has been approved by the Clinical Research Ethics Committee of the hospital performing the study.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Impact of Self-visualization of Epileptic Seizures on Patients' Perception of the Disease and Risk Behavior (VICE)
Actual Study Start Date :
Jan 12, 2017
Actual Primary Completion Date :
May 31, 2019
Actual Study Completion Date :
Feb 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: self seizures visualization group

Visualization of the own epileptic seizures occured during hospital admission.

Procedure: own seizures visualization
At the hospital discharge, patients

No Intervention: usual management

Usual way management

Outcome Measures

Primary Outcome Measures

  1. change from baseline patient's perception of the severity of his or her own disease [five minutes pre-visualization and five minutes post-visualization of self seizures, and three months later.]

    self reported perceived severity of the disease through a visual analog scale (VAS).

  2. change from patient's habits/risk behavior [five minutes pre-visualization and five minutes post -visualization of self seizures, and three months later]

    conducted interview through several questions in the VICE questionnaire, related to intention of change risky behavior habits

Secondary Outcome Measures

  1. baseline quality of life [During the hospital admission (pre visualization of self seizures)]

    measure of the quality of life specifically in patients with epilepsy, through the Quality of Life in Epilepsy Inventory-10(QUOLIE-10), validated spanish version. This inventory ranges from 10 to 50. The higher the score, the worse quality of life.

  2. baseline severity of depressive symptoms [During the hospital admission (pre visualization of self seizures)]

    self reported severity of depressive symptoms through the Beck Depression Inventory Second Edition (BDI-II), validated spanish version. This inventory ranges from 0 to 63. The higher the score, the highest severity of depressive symptoms.

  3. anxiety trait and state [five minutes pre-visualization and five minutes post -visualization of self seizures]

    self reported anxiety trait and state through the State-Trait Anxiety Inventory-STAI, validated spanish version. Scores range from 20 to 80, with higher scores correlating with greater anxiety. This is a two part questionnaire. The state part will be reported five minutes pre and post visualization of self seizures, while the trait part will be reported only five minutes pre visualization.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. for the control group: patients aged 18 years or older admitted to the Epilepsy Unit of Hospital del Mar who voluntarily accept to participate in the study after prior psychological assessment.

  2. for the control group: patients admitted to the Epilepsy Unit of Hospital Germans Tries who voluntarily accept to participate in the study.

Exclusion Criteria:
  • Patients with no risk behavior according to the ad hoc questionnaire administered on admission.

  • Cognitive impairment preventing adequate comprehension of the study.

  • Vision-impaired patients and those with language barriers.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Parc de Salut Mar
  • Germans Trias i Pujol Hospital

Investigators

  • Principal Investigator: Isabel Flores, Parc de Salut Mar

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Isabel Flores, Registered Nurse, Parc de Salut Mar
ClinicalTrials.gov Identifier:
NCT04311151
Other Study ID Numbers:
  • CEIm-PSMAR 2016/6859/I
First Posted:
Mar 17, 2020
Last Update Posted:
Mar 17, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Isabel Flores, Registered Nurse, Parc de Salut Mar
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2020